InvestorsHub Logo
Post# of 253200
Next 10
Followers 839
Posts 120482
Boards Moderated 18
Alias Born 09/05/2002

Re: poorgradstudent post# 174115

Wednesday, 07/23/2014 7:22:11 PM

Wednesday, July 23, 2014 7:22:11 PM

Post# of 253200
INCY’s phase-3 trial of Jakafi in polycythemia vera does not meet primary endpoint:

http://finance.yahoo.com/news/incyte-announces-top-line-results-201500555.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.